Drug Tariff News
17th September 2024 - Source: Amanda Chell
August Drug Tariff News
Additions to Part 2
4 items have been added to Part 2 in the August Drug Tariff. Ones which DDS think you may find of interest are:
- Aquipta tablets (ALL)
- Mayzent 0.25mg tablet
- Mayzent 2mg tablets
- Tafinlar 75mg capsules
Generally, items which fall into Part 2 of the Drug Tariff have no wholesaler discount, you are potentially dispensing at a loss. You may consider sending the prescription away to a local Pharmacy to be dispensed.
Additions to Part 8a
8 items have been added to Part 8a of the August Drug Tariff. Ones which I think you will find of interest are:
- Follitropin alfa 300units/0.48ml, 450units/0.72ml, 900 units/1.44ml solution for injection pre-filled disposable devices have been added to the August Drug Tariff as Category C items and the reimbursement is based on Gonal-f. These items were previously in the Drug Tariff but for slightly different quantities. So basically, previous quantity has been deleted and new quantity added.
- Tirzepatide 12.5mg/0.6ml + 15mg/0.6ml solution for injection 2.4ml pre-filled disposable devices have been added to the August Drug tariff and the reimbursement price is based on Mounjaro KwikPen
- Quetiapine 400mg tablets have gone into the Drug Tariff as a Category C, reimbursement price of £25.00 based on Accord UK Ltd. Other strengths of straight release Quetiapine are already in the Drug Tariff, sitting as Category M items and are significantly over tariff price.
Deletions to Part 8a
There have been 14 deletions to Part 8a in the August Drug Tariff.
Ones which I think you may find of interest are:
- Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/ 24hours transdermal patches pack size of 12 has been deleted from the August Drug Tariff – the pack size of 4 still remains. This product is more commonly known as FemSeven Conti.
- Exenatide 10micrograms/0.04ml solution for injection 2.4ml pre-filled disposable devices more commonly known as Byetta has been removed from the August Drug Tariff. This product was discontinued in April 24.
- Nicotine 1.5mg lozenges sugar free more commonly known as NiQuitin Minis have been removed from the August Drug Tariff. These have been discontinued for a number of years. Other strengths of NiQuitin are still available.
As a reminder Items which have been removed from the Drug Tariff part 8A can still be prescribed and dispensed but you will need to endorse the prescription with manufacturer, pack size and price paid.
Deletions to Part 16 (Notes on Charges)
CONTRACEPTIVE SERVICES, SEXUAL HEALTH RELATED TREATMENT AND HRT PPC
List of medicines covered by the HRT PPC
HRT hormones
Product name Generic Drug Name (VMPs) Bedol
Note: This product is now discontinued -from 1 August 2024 it will no longer be in scope for the HRT PPC
Estradiol 2mg tablets- Climanor
Note: This product is now discontinued -from 1 August 2024 it will no longer be in scope for the HRT PPC
Medroxyprogesterone 5mg tablets -Clinorette
Note: This product is now discontinued -from 1 August 2024 it will no longer be
in scope for the HRT PPC
Generic Clinorette tablets
Other Changes to Part 8a
13 items are listed in ‘Other Changes, Ones which we think you may find of interest are:
- Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion has remained as a Category C item but previously the reimbursement price was based on Zineryt, is now based on Neon Healthcare Ltd. The reimbursement price has increased significantly.
- Octreotide 50micrograms/1ml solution, 500micrograms/1ml solution and 100micrograms/1ml solution for injection pre-filled syringes have all moved from a Category A to a Category C and the reimbursement price is now based on Kent Pharma (UK) Ltd.
- All strengths of Tapentadol modified release tablets have remained as a Category C but Palexia SR has been removed as the Manufacturer which the price is based on however the reimbursement price has remained the same. This is one to watch!
As a reminder -as from 1st July all prescriptions for Zoladex, Prostap, Staladex and Decapeptyl (whether written branded or generically) need to have SLS endorsed in the main body of the prescription.
From 1st July, any prescriptions for the above without the SLS endorsement will be disallowed.
SystmOne and Emis Web should activate this endorsement for you but you each need to check.
Also any prescriptions dated pre July for the GnRH but submitted for payment after 1st July, will need to have SLS endorsed in main body of the prescription.
